Becton-Dickinson Ultra Fine III Short Insulin Pen Needle – 31GX8MM, 100 box

Becton-Dickinson Ultra Fine III Short Insulin Pen Needle - 31GX8MM, 100 box - CLICK HERE TO LEARN MORE

The BD Ultra-Fine™ Short Pen Needle is 31 gauge, 8 mm (5/16"). No pen needle is thinner. It is BD’s best-selling pen needle. The majority of people who take insulin – 82% – get effective results with this needle, but some people, many of whom are overweight, do not.1 You should consult with a health care professional before switching to a shorter pen needle.Paper tab and inner shield are color-coded blue for easy size/gauge recognition.NOTE: Today’s insulin needle is thinner and more delicate for greater comfort, so needle reuse can damage the tip and cause injury. To ensure maximum safety and comfort, you should never use a syringe or pen needle more than once. For more details, see our web page on the risks of needle reuse. BD Ultra-Fine™ Pen Needles fit all diabetes pens and dosers sold in the U.S., including the pens for Lantus® and Apidra®, all Eli Lilly and Novo Nordisk insulin pens, and the pen for Exenatide. All BD pen needles are… Engineered with optimal point geometry for maximum comfort and reliability  Coated with special Micro-Bonded™ lubrication for a more comfortable injection  Manufactured with the finest surgical steel available  Subject to 100% needle point inspection to assure consistent high quality  Non-toxic, non-pyrogenic and DO NOT CONTAIN LATEX  1. In a clinical trial, 18% of patients, most of whom were overweight, had elevated blood glucose when using the BD Ultra-Fine™ III Short Pen Needle when compared with a 12.7 mm (1/2") needle. Data on file at BD. * Among major insurance plans that cover pen needles

**** CLICK HERE TO LEARN MORE ****

Becton-Dickinson Ultra Fine III Short Insulin Pen Needle – 31GX8MM, 100 box

Similar Items:

Share and Enjoy:
  • Digg
  • del.icio.us
  • Facebook
  • NewsVine
  • Reddit
  • StumbleUpon
  • Google Bookmarks
  • Yahoo! Buzz
  • Twitter
  • Technorati
  • Live
  • LinkedIn
  • MySpace
  • TwitThis

Comments are closed.